Insights

Focus on Neuroscience Lundbeck's exclusive specialization in neuroscience offers targeted opportunities to provide specialized services, technology solutions, and partnerships that support brain health research and development.

Global Market Presence With products available in over 100 countries and operations in more than 50, Lundbeck presents a vast market for expansion, distribution partnerships, and localized support services.

Innovative Pipeline Recognition such as the Fast Track Designation for investigational drugs indicates a robust pipeline, creating opportunities for clinical trial collaborations, supply chain solutions, and innovative medical technologies.

Strategic Acquisitions The recent acquisition of Longboard Pharmaceuticals signals Lundbeck's growth strategy and openness to collaborative R&D ventures, offering potential for joint innovation and co-marketing opportunities.

Research & Partnerships Active collaborations with research entities like Charles River Laboratories and Mental Health organizations highlight opportunities to offer research services, data analytics, and mental health solutions aligned with Lundbeck’s mission.

Similar companies to Lundbeck

Lundbeck Tech Stack

Lundbeck uses 8 technology products and services including Hotjar, Autodesk Revit, SuccessFactors, and more. Explore Lundbeck's tech stack below.

  • Hotjar
    Analytics
  • Autodesk Revit
    Cad & Graphics
  • SuccessFactors
    Human Resource Management System
  • Amazon ALB
    Load Balancers
  • Office 365
    Office Suites
  • Windows 10
    Operating Systems
  • AVEVA
    Operations
  • Vimeo
    Video Players

Media & News

Lundbeck's Email Address Formats

Lundbeck uses at least 1 format(s):
Lundbeck Email FormatsExamplePercentage
FLast@lundbeck.comJDoe@lundbeck.com
69%
First.Last@lundbeck.comJohn.Doe@lundbeck.com
18%
Last.F@lundbeck.comDoe.J@lundbeck.com
7%
Last@lundbeck.comDoe@lundbeck.com
6%

Frequently Asked Questions

Where is Lundbeck's headquarters located?

Minus sign iconPlus sign icon
Lundbeck's main headquarters is located at H. Lundbeck, Ottiliavej 9, Valby, Copenhagen 2500, DK. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Lundbeck's stock symbol?

Minus sign iconPlus sign icon
Lundbeck is a publicly traded company; the company's stock symbol is LUN.CO.

What is Lundbeck's official website and social media links?

Minus sign iconPlus sign icon
Lundbeck's official website is lundbeck.com and has social profiles on LinkedInCrunchbase.

How much revenue does Lundbeck generate?

Minus sign iconPlus sign icon
As of October 2025, Lundbeck's annual revenue is estimated to be $5B.

What is Lundbeck's NAICS code?

Minus sign iconPlus sign icon
Lundbeck's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lundbeck have currently?

Minus sign iconPlus sign icon
As of October 2025, Lundbeck has approximately 6.1K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer: S. M.Vice President Commercial Excellence: E. C. M.Vice President Commercial & Corporate Strategy Neurology: T. B.. Explore Lundbeck's employee directory with LeadIQ.

What industry does Lundbeck belong to?

Minus sign iconPlus sign icon
Lundbeck operates in the Pharmaceutical Manufacturing industry.

What technology does Lundbeck use?

Minus sign iconPlus sign icon
Lundbeck's tech stack includes HotjarAutodesk RevitSuccessFactorsAmazon ALBOffice 365Windows 10AVEVAVimeo.

What is Lundbeck's email format?

Minus sign iconPlus sign icon
Lundbeck's email format typically follows the pattern of FLast@lundbeck.com. Find more Lundbeck email formats with LeadIQ.

How much funding has Lundbeck raised to date?

Minus sign iconPlus sign icon
As of October 2025, Lundbeck has raised $566M in funding. The last funding round occurred on May 22, 2025 for $566M.

When was Lundbeck founded?

Minus sign iconPlus sign icon
Lundbeck was founded in 1915.
Lundbeck

Lundbeck

Pharmaceutical ManufacturingDenmark5001-10000 Employees

Lundbeck is a global pharmaceutical company solely focused on neuroscience. We cover the full value chain, from molecule to patient, in this rapidly evolving area of treatment. 

For more than 70 years we have maintained our focus on neuroscience. Our legacy and commitment to breakthrough innovation provide the foundation for developing truly transformative treatments for neuro-rare and neuro-specialty conditions. 

We are 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France, and Italy. 

Our curiosity, accountability, and adaptability enable us to advance brain health and transform lives. Whether we work in labs, at desks, or in the field, we work closely with patients, healthcare professionals, and the neuroscience community to uncover causes, find new treatments, and fight stigma and discrimination. We want to go faster and further on addressing the significant unmet needs of people living with brain disorders.

Section iconCompany Overview

Headquarters
H. Lundbeck, Ottiliavej 9, Valby, Copenhagen 2500, DK
Stock Symbol
LUN.CO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1915
Employees
5001-10000

Section iconFunding & Financials

  • $566M

    Lundbeck has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $566M

    Lundbeck has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.